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A GLOBAL PHYSICIAN-ORIENTED MEDICAL
INFORMATION SYSTEM
AXEL BOLDT AND MICHAEL JANICH
Abstract. We propose an Internet-based, free, world-wide, cen-
tralized medical information system with two main target groups:
practicing physicians and medical researchers. After acquiring pa-
tients’ consent, physicians enter medical histories, physiological
data and symptoms or disorders into the system; an integrated
expert system can then assist in diagnosis and statistical software
provides a list of the most promising treatment options and medi-
cations, tailored to the patient. Physicians later enter information
about the outcomes of the chosen treatments, data the system
uses to optimize future treatment recommendations. Medical re-
searchers can analyze the aggregate data to compare various drugs
or treatments in defined patient populations on a large scale.
1. Introduction
The two main tasks performed by physicians are:
• diagnosing a disorder, based on presented symptoms, the pa-
tient’s medical history and features, and ordered tests; and
• choosing the most appropriate treatment or medication for a
given disorder and a given patient.
In this article we propose a medical information system which aims to
assist physicians in both these tasks.
The ever increasing number of recognized diseases, combined with
an explosion in the number of marketed medications, poses formidable
challenges to the practicing physician. Many physicians rely mainly on
four information sources: their often outdated text books and lecture
notes, a small selection of medical journals, possibly biased informa-
tional material from pharmaceutical companies, and their personal or
anecdotal experiences. All of these are less than ideal, and we maintain
that they can and should be supplemented by more rational decision
aids based on modern data mining technology.
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The core idea is simple: an expert system and treatment database
that physicians access over the Internet. After acquiring informed con-
sent, they enter a patient’s physiological data, symptoms and test re-
sults and the expert system aids in diagnosis or recommends further
tests. Once the disorder is identified, the system recommends those
treatments or medications with the highest success probability for that
particular patient. The physician chooses a treatment and later records
the outcome in the database. This outcome data is used by the system
to improve future treatment recommendations.
The system is designed to be used by physicians world wide, with
special regard for those working in developing countries. The use will
be free of charge and will only require an ordinary modem-speed con-
nection to the internet, something that is now available at reasonable
cost in most countries, often via mobile phones.
Since cost is often an important criterion when choosing a treatment
or medication, the system’s recommendations will be accompanied by
cost estimates specific to the physician’s location.
The two components of the system, diagnostic expert system and
treatment recommendation engine, use the same underlying patient
database but are logically independent and the system can go online
as soon as one of the two is fully functional. For example, physicians
can eschew the expert system altogether, rely on their own diagnostic
skills and directly ask for treatment recommendations for a particular
patient’s disorder.
Apart from aiding physicians in their decision processes and thus
improving care and lowering cost on a global scale, the collected data
will also provide a rich resource for medical researchers. It will be
possible to easily determine the effectiveness of treatments and drugs
in various patient populations defined by combinations of characteris-
tics such as age, sex, ethnic group, pre-existing conditions, lifestyle, or
any of a large number of physiological measurements recorded by the
system. In addition, the system will be immediately useful by help-
ing to compare new, expensive and heavily marketed medications with
older, more established alternatives. Evaluation of alternative treat-
ments like acupuncture or herbal remedies, heavily used all over the
world but rarely studied in a rigorous manner, will also become much
easier. Newly emerging epidemics will be detected in real time, much
earlier than is possible today. Lastly, it is likely that mining the data-
base will uncover rare but severe side effects of established medications
that have so far escaped detection.
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2. Detailed Description
2.1. Recruitment of physicians. The system will be open to all
licensed practicing physicians world-wide. Apart from the costs of a
regular Internet connection, use of the system will be free. Rather
than attempting to contact all physicians directly, or to advertise in
relevant publications, it is hoped that the national medical associations
of the various countries can be recruited to promote the system to
their members and provide them with authorized access codes. This
approach has three advantages over a more direct marketing campaign:
• it is significantly cheaper;
• verification of physician’s credentials is done by the organiza-
tions best suited for the task;
• physicians extend a natural goodwill bonus to communications
from their respective medical association.
2.2. Physicians’ interaction with the system. Physicians are pro-
vided with access codes (passwords). They will normally interact with
the system by accessing the project’s website and logging in with their
name and password. The website will follow W3-standards and carry
few graphics in order to be easily accessable through slow modem con-
nections and simple devices, including mobile devices. It will be de-
signed to make the most common interactions simple and fast.
When accessing the system for the first time, new users are directed
to a tutorial about the system’s features and are required to agree
to a set of rules, mainly pertaining to patients’ informed consent and
privacy (discussed below in section 2.3).
In the standard use case, after authentication physicians are pre-
sented with a list of their patients and past treatments and are invited
to input outcome data for these treatments in a quick and simple man-
ner. They are then able to view their patients’ records, create new
records, use the expert system to receive diagnostic assistance, or use
the statistical database to get treatment/medication recommendations.
The top-rated treatments will be presented along with estimates of
their success probability and their cost. The system further facilitates
the physician’s decision process by providing easy access to relevant
background information, such as as reviews from the Cochrane Library
([2]) and medical guidelines from the clearinghouse responsible for the
physician’s location ([1], [5]).
Signs, symptoms and diseases will be entered using the well-known
ICD-10 classification system ([3]), and information about medications
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will be accessable through the standard Anatomical Therapeutic Chem-
ical Classification System ([4]). It is to be expected that these systems
will not be entirely adequate for our purposes and will have to be mod-
ified and extended to a certain degree.
In addition to the direct web-based interface, the system will also
provide an XML-based interface, allowing for the easy data exchange
with physicians’ other software applications, for instance with their
standard patient management software or with their systems of inter-
facing with health insurers.
All patient information data transport will employ a layer of encryp-
tion to avoid data being viewed or tampered with by unauthorized
third parties.
2.3. Patient identifiers and privacy issues. The system will obey
the world’s strictest privacy laws, like those commonly found in coun-
tries of the European Union. This requires in particular that
• data is collected with full consent and can only be used for the
express purposes given in the consent statement; and
• patients retain the right to review their data and to have it
removed at any time.
Physicians are required to obtain informed consent before they may
enter patients’ data into the system. Physicians are not allowed to re-
ject treatment of patients who do not wish to participate in the system.
No personally identifiable information is ever entered into the data-
base: no names, no exact birthdates, no addresses etc. Instead, every
patient is identified by a PatientID, a simple number. The physician
provides the patient with their PatientID, so that the patient can au-
thorize other physicians to access their data if they so choose. Only
physicians explicitly authorized by a patient may access the records
associated with that patient’s PatientID; physicians are required to
keep proof of this authorization on file. Physicians will typically keep
a record of all their patients’ PatientIDs on their own computer.
It is possible and even to be expected that patients’ names together
with corresponding PatientIDs will occasionally fall into the wrong
hands, for instance if malware is installed on a physician’s computer,
their office is broken into or a patient’s private PatientID note is stolen.
Since only physicians associated with the PatientID may access the cor-
responding record, the risk of data leaks is actually lower than in the
current situation, where all patient data would have been stored on the
doctor’s compromised computer rather than in the online database.
Physicians, unlike patients, do not remain anonymous and are recorded
with full name and address in the database. Further, all interactions
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of physicians with the system are logged. This allows to trace and
identify fraudulent use by non-physicians.
During scientific analysis the database will only be queried in the
aggregate and no individual record will be accessed in its entirety. It is
however important to note that this does not completely protect against
abuses; for instance a query of the form ”what percentage of adult black
males living in Luxembourg and standing less than 1.6 m tall are HIV
positive”, even though it uses the database only in the aggregate, can
still reveal very private information about a small number of identifiable
individuals. It is therefore necessary that scientific analyses be reviewed
ahead of time; see section 2.5 below for more details on this process.
2.4. Software. To maximize transparency and to encourage others to
submit bug fixes and feature enhancements, the project will make use
of existing Open Source software whenever possible and all software
written by the project will be published under an Open Source license
([7]).
Diagnostic expert systems have been developed before ([8]; [6] for
a comprehensive annotated list), and it is unrealistic to expect the
project to duplicate that work. Instead, existing expert systems will be
evaluated and the most appropriate one will be licensed and extended.
Most modern systems of this type employ Bayesian networks, and these
would benefit tremendously from the statistical knowledge stored in the
patient database.
The treatment recommendation engine will have to be written from
scratch, using existing algorithms that have been developed for data
mining applications in marketing; given a database containing customer
features and outcomes of past marketing strategies, these algorithms
can predict the most promising marketing strategy taylored to a given
customer. (See [9] for a survey of data mining algorithms.) The algo-
rithm will have to account for the fact that information about patients
is not necessarily complete; for example, only some patient records will
contain a recent blood glucose level.
As is usual in data mining applications, the comparatively low qual-
ity of data collection procedures is compensated for by the large quan-
tity of data. A variety of different heuristics can be used to approach
the recommendation problem and a final algorithm can only be chosen
after empirical evaluation.
As mentioned above, the system requires information about the
prices of treatments and medications in the various countries. It is
possible and desirable that the collection and maintenance of this data
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be carried out in collaboration with the various national medical asso-
ciations. The problem is non-trivial, since drug prices can vary widely
even within countries.
2.5. Scientific analysis of the collected aggregate data. For rea-
sons outlined in section 2.3 above, it is necessary that all research
proposals be reviewed ahead of time. Credentialed medical researchers
may submit research proposals explaining the study’s rationale, accom-
panied by the software that is to analyze the database. After review of
proposal and software, the software is run against the live database and
the results are returned to the researcher. Research proposal, analysis
software and results are made public to ensure that negative results are
not suppressed. The entire process is free of charge for the researcher.
Toy systems with the same database structure as the live system
(but without real-world data) are provided to researchers, so that their
analysis software can be tested and debugged ahead of time. The use of
free software, as described in section 2.4 above, will hopefully result in
a rich ecosystem of analysis software freely shared among researchers.
Every statistical analysis of the systems database needs to take into
account that the system does not and cannot guarantee that differ-
ent PatientIDs always correspond to different patients. Furthermore,
conclusions based on analysis of the database are of course valid only
for the subpopulation of patients who are cared for by participating
physicians and who have given consent to participating in the system;
this may not be a representative sample. External studies compar-
ing this subpopulation to the general patient population will be highly
desirable.
As with all data mining applications, correlations discovered in the
data will have to be confirmed by traditional randomized trials.
2.6. Organizational structure and funding. The system will be
developed, deployed and run by a non-profit organization, to be set
up in a jurisdiction that grants tax-free status to such organizations
and that has strong privacy protection laws. The organization will be
assisted by a board of external advisors.
To maintain neutrality and to avoid unduly influences on physicians
decision processes, the system’s website will not carry any advertis-
ings. The project will be financed completely by donations and grants.
These may come from individuals, companies (especially health insur-
ers), charity foundations, or national or international health organiza-
tions. It is possible that an organization such as the NIH’s National
Library of Medicine can be convinced to host and run the system. An
alternative model of funding, especially once the system is established
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and accepted, would have the governments of rich participating coun-
tries pay a (small) set amount per patient.
3. Conclusion and Outlook
The proposed system, once fully implemented, will improve world-
wide medical care in a number of important ways:
• practicing physicians, even in developing countries, will receive
easy and free access to a medical expert system that can assist
in diagnosis;
• physicians receive promising treatment options, tailored to the
patient, based on past collected outcome data;
• inclusion of price data for treatments and medications allows
physicians to choose the most cost-effective option in any given
situation;
• with patients’ consent, medical histories stored in the database
are easily transferrable from one physician to another;
• creative use of the collected aggregate data will allow medical
researchers to identify subpopulations of patients that respond
particularly well to a certain medication or treatment;
• comparisons of new drugs with established generic medications
for the same condition become straightforward.
In the future, the system can be extended to incorporate patients’
genotype data, thereby representing an important step towards the
longstanding goal of truly personalized medicine.
In addition to these quite concrete and immediate benefits, we would
like to express our hope that widespread adoption of the system will
cause the profession of physician to evolve: from a passive container of
knowledge about symptom-disease correlations and disease-treatment
success probabilities to an active partner of the patient who reassures,
explains disorders and treatments, inquires and provides advice about
the patients life circumstances and in general maximizes the placebo
effect in every way possible. This, we believe, will ultimately turn out to
be one of the main benefits of the proposed system: the placebo effect,
long considered a quirky nuisance by western medicine, will return to
its rightful place at the center of the healers work. Traditional systems
of medicine will have much to teach to physicians freed from the more
mundane tasks of their profession.
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